Area of Research: PARP Inhibitors
2021 Grant Recipients
- Sridevi Challa, PhD, UT Southwestern Medical Center Mentored Investigator GrantRole of Ribosomal Protein Mono(ADP-ribosyl)ation in Protein Quality Control
- Benoît Bragantini, PhD, Mayo Clinic Mentored Investigator GrantProbing Homologous Recombination DNA Repair Factors in Chromatin by cryo-EM
- Ichiko Kinjyo, MD, PhD, University of New Mexico Early Career Investigator GrantA Novel Mechanism for the Immunomodulatory Effects of PARP-inhibitor
- Arun Kanakkanthara, PhD, Mayo Clinic Early Career Investigator GrantExploiting a Metabolic Dependency of PARPinhibitor-Resistant Ovarian Cancer
- Liya Ding, PhD, Dana Farber Cancer Institute Early Career Investigator GrantTargeting Therapeutic Resistance to PARP Inhibition in Ovarian Cancer
- Ivan Ahel, PhD, University of Oxford Collaborative Research Development GrantExploiting PARP-Modulating Enzymes in Ovarian Cancer Therapy
2020 Grant Recipients
- Nidhi Sahni, PhD, MD Anderson Cancer Center Early Career Investigator GrantSystems Approach for PARP-based Novel Combination Therapy in Ovarian Cancer
- Janice Santiago, PhD, MD Anderson Cancer Center Mentored Investigator GrantCrizotinib Improves the Therapeutic Efficacy of Olaparib in Ovarian Cancer
2019 Grant Recipients
- Sarah Gitto, PhD, University of Pennsylvania Mentored Investigator GrantModeling Autologous TIL Therapy in Novel PARP Resistant PDX Model for Ovarian Cancer
- Marilyne Labrie, PhD, Oregon Health and Science University Mentored Investigator GrantSynergistic Lethality of PARP and P13K Pathway Inhibitors in Ovarian Cancer
- Shariska Petersen, MD, University of Kansas Medical Center Research Institute Mentored Investigator GrantCyclin E and BRD4 as Markers for a New PARPi Drug Combination
2018 Grant Recipients
- Shih-Hsun Chen, PhD, Beckman Research Institute of the City of Hope Mentored Investigator GrantTargeting de-poly (ADP-ribosyl)ation for Ovarian Cancer Therapy
- Maria Victoria Botuyan, PhD, Mayo Clinic Early Career Investigator GrantProbing the Antagonistic Roles of 53BP1 and RAD18 in HR DNA Repair
- Jian Yuan, PhD, Mayo Clinic Early Career Investigator GrantThe Role of BRD9-Rad51 Axis in Chemoresistance in Ovarian Cancer
2017 Grant Recipients
- Anniina Farkkila, MD, PhD, Dana Farber Cancer Institute Mentored Investigator GrantOvercoming PARP Inhibitor Resistance in Ovarian Cancer
2015 Grant Recipients
- Sarah Adams, MD, University of New Mexico Early Career Investigator GrantA Combination Therapy for Hereditary Ovarian Cancer
2014 Grant Recipients
- Barbara Stulken Norquist, MD, University of Washington Early Career Investigator GrantMolecular Biomarkers to Predict PARP Inhibitor Response in Ovarian Cancer
- Mo Li, PhD, University of Michigan Mentored Investigator GrantMechanism of PARP Inhibitor in Ovarian Cancer Therapy Cancer
2013 Grant Recipients
- Elizabeth Swisher, MD, University of Washington Collaborative Research Development GrantThe FA-BRCA Pathway and Response to Platinum and PARP Inhibitors in Ovarian, Tubal and Peritoneal Carcinomas
2012 Grant Recipients
- See-Hyoung Park, PhD, Stanford University Mentored Investigator GrantTargeting Ovarian Cancer with Combination of Olaparib and Bepridil
2011 Grant Recipients
- Sarah Adams, MD, University of Pennsylvania Early Career Investigator GrantDevelopment of Combination Therapy with PARP-Inhibitors and Immunomodulation for BRCA1-Epithelial Ovarian Cancer
2008 Grant Recipients
- Lejla Delic, MD, Cedars-Sinai Medical Center Mentored Investigator GrantA New Class of Drugs with Potential Against Ovarian Cancer: PARP-inhibitors